Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
ASML reports transactions under its current share buyback program
-
Ardena strengthens executive leadership with appointments of Chief Quality Officer and Chief Information Officer
-
STMicroelectronics announces status of common share repurchase program
-
Orchestra BioMed to Host Business Update Call on November 12, 2025
-
Teva Kicks Off ‘The Other TD’ to Raise Awareness of Tardive Dyskinesia (TD), with Support from Pro Football Hall of Famer Terrell Davis
-
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Globo Comunicação e Participações S.A. Announces Launch of Cash Tender Offers
-
iFLYTEK AINOTE 2 Set to Sell Globally on November 1, 2025, Redefining Professional Productivity with Advanced AI
-
Ramsey Theory Group CEO Dan Herbatschek Publishes Five Key ROI Metrics for Enterprise AI and Reveals the One Critical Mistake
-
Stellar Pictures Brings High-Profile IPs to Cannes & London, Showcasing Chinese Culture
-
Stellar Pictures Brings High-Profile IPs to Cannes & London, Showcasing Chinese Culture
-
Luvme Hair Announces 2025 Black Friday Wigs Sale and Saving Guide
-
Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.08 Per Share for November 2025
-
ARS Pharma to Present Real-World Data on Intranasal Epinephrine at 2025 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting
-
ARS Pharma to Present Real-World Data on Intranasal Epinephrine at 2025 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting
-
MDC Releases Commentary: Digital Wallet Oversight—What New U.S. Payment App Rules Mean for Casino Transactions
-
First American Uranium Inc. Announces Change of Stock Symbol and Uplisting to the OTCQB Venture Market
-
QGold Commences Trading on OTCQB® under QGLDF on the Venture Market
-
L.B. Foster Announces Continuing Sales Growth and Robust Cash Generation in Fiscal Third Quarter with Expected Strong Finish to 2025
-
Rein Therapeutics Receives FDA Clearance to Resume U.S. Phase 2 Trial of LTI-03 in Idiopathic Pulmonary Fibrosis
-
Altimmune Announces Early Completion of Enrollment in RECLAIM Phase 2 Trial Evaluating Pemvidutide in Alcohol Use Disorder
-
Kalaris Expands Leadership Team Appointing Matthew Gall, MBA, as Chief Financial Officer
-
Kailera Therapeutics Appoints Frank Clyburn to Board of Directors
-
Apogee Therapeutics to Participate in Upcoming Conferences
-
DeFi Crypto Mutuum Finance (MUTM) Details V1 Launch Roadmap as Phase 6 Nears 90% Allocation
-
NIP Group Expands Bitcoin Mining Capacity with Additional Asset-Purchase Agreement
-
Genie Energy Announces Third Quarter 2025 Results
-
Digi Power X Strengthens Balance Sheet to Support 2026 AI Infrastructure Development Plan
-
Dyne Therapeutics to Present at Upcoming Investor Conferences
-
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
BridgeBio to Present Data from the Overall ATTR-CM Variant and V142I (V122I) Populations from ATTRibute-CM at the AHA Scientific Sessions 2025
-
Osisko Development Strengthens Technical Team With Appointment of Vice President, Exploration
-
Phoenix Asia Holdings Limited Announces Addition to Board of Directors
-
Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences
-
Biogen to Highlight Scientific Progress in Rare Kidney Disease at American Society of Nephrology (ASN) Kidney Week 2025
-
InspireMD Names Peter A. Soukas, M.D., as Chief Medical Officer
-
Nexxen Announces October 2025 Share Repurchase Program Summary
-
HSBC Continental Europe: Pre Stabilisation Notice
-
Willis Lease Finance Corporation Announces New Revolving Credit Facility for Joint Venture, Willis Mitsui & Co. Engine Support Limited
-
Willis Lease Finance Corporation Announces New Revolving Credit Facility for Joint Venture, Willis Mitsui & Co. Engine Support Limited
-
Bombardier Announces Notice of Redemption for All of its 7.875% Senior Notes due 2027
-
MGA’s Miniverse™ Brings Minecraft™ to Life in Miniature with New Make It Mini™ Collection
-
Cipher Mining Provides Third Quarter 2025 Business Update
-
Benitec Biopharma Provides Positive Interim Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial and Receives FDA Fast Track Designation for BB-301
-
FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM
-
uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease
-
Unicycive Therapeutics to Participate in a Fireside Chat at the Guggenheim 2nd Annual Healthcare Innovation Conference
-
Kraig Biocraft Laboratories Confirms Spider Silk Production Operations Unaffected by Southeast Asia Typhoons due to Strategic Relocations to Highland Over Last 24 Months
-
Vertex Announces Third Quarter 2025 Financial Results and $150 Million Class A Common Stock Repurchase Program
-
New Report Reveals Disconnect Between Short-Term Focus and Long-Term, Data-Backed Growth Strategies for Health Systems
